FDA Approves Marketing of First Condom Designed for Anal Sex
Condom was approved through the De Novo premarket review pathway for low- to moderate-risk devices of a new type
COVID-19 Survivors at Higher Risk for New Behavioral Health Issues
People who survived the first 30 days of SARS-CoV-2 had increased risk for anxiety, depression, stress and adjustment, sleep, and substance use disorders
CDC Close to New Guidance on COVID-19 Restrictions
Agency wants to give more emphasis to meaningful consequences such as hospitalizations, emergency room visits, and deaths
Hepatitis C Virus Positivity Linked to Schizophrenia Development
Incidence of overall mortality was also highest for untreated patients with hepatitis C virus
Ivermectin Does Not Prevent Progression to Severe COVID-19
No impact on progression to severe disease seen for high-risk patients with mild-to-moderate disease receiving ivermectin during early illness
Social Vulnerability Linked to Increased Severity of COVID-19
Once hospitalized, patients did not experience differences in hospital mortality, discharge disposition
New Sanofi-GSK COVID-19 Vaccine Highly Effective, Companies Say
In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine
Most Free COVID-19 Tests Have Shipped: White House
Last month, about 60 million orders for the free tests were received within 10 days after launching the initiative
COVID-19 Travel Rules to Europe May Be Lifted for Vaccinated
EU-authorized vaccines include those from Pfizer, Moderna, AstraZeneca, Johnson & Johnson, and Novavax
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Of 1,366 patients with immediate allergic reaction to first dose, six developed severe immediate allergic reaction after second dose
